Bioequivalence evaluation of norfloxacin 400 mg tablets (Uroxin® and Noroxin®) in healthy human volunteers

Biopharmaceutics and Drug Disposition

Volumn 21, Issue 5, 2000, Pages 175-179

  Al rashood, Khalid A ^a   Al khamis, Khalil I ^b   El sayed, Yoursy M ^b   Al bella, Sulaiman ^a   Al yamani, Mohd A ^b   Alam, S Mahmood ^a   Dham, Ruwayda ^b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b Gulf Pharmaceutical Industries   (United Arab Emirates)

Author keywords

Bioequivalence evaluation; Human volunteers; Norfloxacin

Indexed keywords

NORFLOXACIN; UROXIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; CLINICAL TRIAL; CROSSOVER PROCEDURE; DRUG FORMULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; TABLET;

ADULT; ANTI-INFECTIVE AGENTS; AREA UNDER CURVE; CHEMISTRY, PHARMACEUTICAL; CROSS-OVER STUDIES; HUMANS; MALE; MIDDLE AGED; NORFLOXACIN; TABLETS; THERAPEUTIC EQUIVALENCY;

EID: 0034495980     PISSN: 01422782     EISSN: None     Source Type: Journal    
DOI: 10.1002/1099-081X(200007)21:5<175::AID-BDD228>3.0.CO;2-5     Document Type: Article

References (26)

1. A distribution-free procedure for the statistical analysis of bioequivalence studies
2. Quinolone antibacterial: An update of their pharmacology and therapeutic use
3. Norfloxacin: A new targeted fluoroquinolone antimicrobial agent
4. Investigations into the mechanism of action of the antibacterial agent norfloxacin
5. In vitro activity of norfloxacin, a quinolinecarboxylic acid, compared with that of betalactams, aminoglycosides, and trimethoprim
6. Recent advances in pharmaceutical chemistry: The 4-quinolone antibiotics
7. Norfloxacin and the antibacterial pyridone B-carboxylic acids
8. Norfloxacin - A review of pharmacology and tissue penetration
9. Inhibition of norfloxacin absorption by dairy products
10. Norfloxacin disposition after sequentially increasing oral doses
11. The pharmacokinetics and tissue penetration or norfloxacin
12. Pharmacokinetics of norfloxacin in healthy volunteers and patients with renal and hepatic damage
13. Recovery of norfloxacin in feces after administration of a single oral dose to human volunteers
14. Quinolone pharmacokinetics
15. Pharmacokinetics and tissue penetration of quinolones
16. Pharmacokinetics of norfloxacin in renal failure
17. Effect of norfloxacin on human oropharyngeal and colonic microflora and multiple-dose pharmacokinetics
18. The accurate, sensitive and reproducible method for the quantitation of pefloxacin in plasma
19. Use of confidence intervals in analysis of comparative bioavailability trials
20. Comparison of different methods of decision making in bioequivalence assessment
21. An exact confidence interval from untransformed data for the ratio of two formulation mean
22. A comparison of two one-sided tests procedure and the power approach for assessing the bioequivalence of average bioavailability